- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology, February 2023
Combatting Future Viral Threats with Vaccine Advances
February 03, 2023
Cover Story
47
2
The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.
Aiming for Improved Efficacy and Patient Compliance for Topical Ophthalmics
February 03, 2023
Development
47
2
Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.
Safeguarding Biologics—Blending Engineering Ingenuity and Managerial Excellence
February 03, 2023
Manufacturing
47
2
Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.
Convergence in the Global Regulatory Village
February 03, 2023
Quality/Regulations
47
2
Harmonization of global regulations fosters innovation and ensures quality medicines.
Supplementary Handwashing Techniques to Improve Hand Hygiene
February 03, 2023
Peer Reviewed
47
2
A fluorescence test method was used to visually evaluate handwashing efficacy. Difficult-to-clean areas on skin such as skin folds and webbing between fingers were identified; specific washing techniques to address problem areas are proposed.
The Punctuated Evolution of Computer Software Validation
February 03, 2023
Quality/Regulations
47
2
Shifting guidance and the growing prominence of computer software assurance exemplify the state of computer software validation.
Advantageous Positioning for Europe in Pharmaceutical Cannabis
February 02, 2023
47
2
The European bio/pharma industry’s high regulatory standards and GMP requirements are set to position the region as a frontrunner for pharmaceutical‑grade manufacturing of cannabis-based medicines.
Harmonizing Rules Governing SPCs for Medicinal Products
February 02, 2023
Regulatory Watch
47
2
A new unified initiative for patent protection in the EU to boost the competitiveness of the pharma industry is nearing completion.
Improving Gender Diversity
February 02, 2023
From The Editor
47
2
Although some headway is being made into more gender-diverse executive levels in pharma, much more work is still needed.
FDA Interactions with Industry Under Scrutiny
February 02, 2023
Regulatory Watch
47
2
A Congressional probe of FDA’s approval of Alzheimer’s treatment targets the agency’s interactions with drug manufacturers.
Technology for In Vivo CAR T-cell Therapy Advances
February 02, 2023
47
2
In vivo CAR-T gene therapies could resolve challenges faced by autologous and allogeneic treatments.
Considerations for Method Validation
February 02, 2023
Ask the Expert
47
2
Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Shiri Hechter, senior lab operations manager for Nelson Laboratories, provide a simple approach to validating analytical methods.
The Commercial Message mRNA Products Send
February 02, 2023
From The Editor
47
2
This new pioneering phase of mRNA is loaded with potential, but also obstacles and false dawns.
Dual Shaft Mixers
February 02, 2023
Product Spotlight
47
2
ROSS’ Dual Shaft Mixers can batch dispersions, suspensions, and emulsions with viscosities up to several hundred thousand centipoise.
Cell Density and Viability Analyzer
February 02, 2023
Product Spotlight
47
2
The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.
Protein Purification Column Packs
February 02, 2023
Product Spotlight
47
2
Bio-Rad Laboratories’ EconoFit Column Packs provide resin screening for customers developing protein purification workflows.
Biologics-Specific qPCR Workflows
February 02, 2023
Product Spotlight
47
2
Thermo Fisher Scientific’s QualTrak is tailored for biologics development.
Proportion, Balance, and Restraint
February 02, 2023
From the CEO
47
2
The restraint to not target solely the major disease groups has provided good proportion and balance for our industry.